What problem is this trying to fix
For years, countries agreed that CITES regulates not only whole animals and plants, but also “readily recognizable parts and derivatives”, without ever being clear about what that phrase meant.
That ambiguity let different governments make very different calls. One might ask for export permits on powders, pills, or carved pieces, while another only stopped whole horns or skins. The point of this decision is to get everyone using the same definition so the rules are more predictable and harder to dodge.
The common‑sense rule
The core idea is pretty simple:
If a product clearly looks, reads, or is presented as coming from a protected species, it should be treated as a regulated wildlife product.
Officials do not have to identify the exact species just by staring at the object. They can look at the label, packaging, shipping papers, or other context. If those suggest it is rhino horn, tiger bone, a certain orchid extract, and so on, then CITES paperwork is required unless that kind of product has been formally exempted.
There is a second piece: if an importing country wants permits for these kinds of products, it should not drop that requirement just because the exporting country has decided they are “not recognizable”. That is there to avoid loopholes between different legal systems.
Bringing biotech into the net
The 2022 update adds one key sentence about new technologies. It tells governments to also treat products made using biotechnology as “readily recognizable” parts or derivatives, so long as they fit the common‑sense test above.
In practice, that means:
- If a lab‑made product is packaged or marketed as rhino horn, bear bile, or any other CITES‑listed material, it can be treated as a regulated wildlife product, even if it was not cut directly from an animal.
- Only products that have been specifically carved out as exceptions are meant to fall outside that rule.
The change makes it much harder to argue that biotech copies of protected wildlife products automatically sit outside existing trade law.
A couple of explicit carve‑outs
To avoid confusion, the text also says that:
- Coral sand and very small coral fragments are not considered “readily recognizable”, so they are not covered by CITES.
- Naturally excreted urine, feces, and ambergris are treated as waste and are also outside the system.
Everything else that obviously appears to be from a listed species is to be handled as a regulated part or derivative, with the usual permits and controls.
